Health News

Surprising Facts About Melanoma
Sunburns and excessive tanning can increase your risk for an aggressive form of skin cancer known as melanoma. Could other habits — such as medication use and even your profession — raise your melanoma risk as well?
Meditation and Yoga May Ease Breast Cancer Anxiety
Chemotherapy, radiation and surgery are all common ways to fight breast cancer. While complementary therapies may not directly treat cancer, many may relieve related worry and stress.
Arthritis Pain Relievers May Raise Risk of Death From Stroke
Arthritis can be painful and prevent patients from doing daily activities. But certain medicines to relieve arthritis pain may increase patients' chances of dying from a stroke, a new study found.
Colorectal Cancer Rate in Young Patients Rose
In recent years, rates of some types of cancers have dropped in older patients. But new research suggests the rate of colorectal cancer may be on the rise in younger patients.
Hospira Recalls Power Supply for GemStar Infusion Pumps
The power supply may not properly deliver electric power to the GemStar Infusion Pump. If the power supply fails, planned infusion therapy may be delayed if a backup power supply is not used.
Air Pollution May Increase Risk of ADHD in Children
Polycyclic aromatic hydrocarbons — usually shortened to PAH — are a component of air pollution. And new research suggests they may raise the risk of ADHD in children whose mothers are exposed to them.
99 Ranch Market Recalls Products Due to Undeclared Allergens
Welcome Market, Inc. dba 99 Ranch Market of Union City, CA is recalling “Taro Toast”, “Family Toast”, “U-Ta-Ne Toast”, “Raisin Toast”, “Green Onion Porksung Toast”, “Coconut Toast”, “Pineapple Toast”, “Multi-9 Grain”, “Cheese Toast”, “Wheat Bran Toast”, and “Red Bean Toast.”
FDA Notifies Public of Hidden Ingredient in V26 Slimming Coffee
The Food and Drug Administration (FDA) is advising consumers not to purchase or use V26 Slimming Coffee, a product promoted and sold for weight loss on various websites and possibly in some retail stores.
FDA Gives Green Light to Ramucirumab in Combination with Paclitaxel
On November 5, 2014, the U. S. Food and Drug Administration approved ramucirumab (Cyramza, Eli Lilly and Company) for use in combination with paclitaxel for the treatment of patients with advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma.
FDA Approves Combo Treatment for Stomach, GE Junction Adenocarcinoma
The US Food and Drug Administration (FDA) today approved a new combination treatment for patients with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma.
<< first333334335336337338339340341last >>

REFINE